Nothing To Sneeze At: Merck Considers An Over-The-Counter Version Of Singulair
This article was originally published in The Pink Sheet Daily
Executive Summary
The drug maker is also weighing whether to find a partner for the Schering-Plough OTC unit it will soon acquire.